Type 2 diabetes. Non-insulin-dependent diabetes mellitus
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria: Type 2 diabetes for at least 6 months, age between 30-60 years, usage of blood glucose lowering drugs Exclusion criteria: usage of nutritional supplements in the past 3 months or during the study, usage of insulin, Pregnancy or lactation, BMI more than 37, Renal failure, liver disease, Cardiovascular disease, thyroid disorders, History of allergy, smoking, alcohol usage, Following a specific diet, Taking corticosteroids or immunosuppressive drugs
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: Enzymatic colorimetric.;Fasting insulin serum. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: ELISA assay.;HbA1C (Glycosilated hemoglobin). Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: ELISA.;Insulin resistance. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: HOMA-IR calculation.;Lipid profiles (TC, TG, LDL-C, HDL-C). Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: Enzymatic methods for TC,TG and HDL-C For LDL-C : Freidwald’s formula: LDL-C = TC- HDL-C - (TG/5).;Serum malondialdehyde(MDA). Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: spectrophotometry.;Serum total antioxidant capacity. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: spectrophotometry.;GPX activity. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: spectrophotometry.;SOD activity. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: spectrophotometry.;Catalase enzyme activity. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: spectrophotometry.;Hc-CRP. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: immunoturbidimetry.;TNF-a. Timepoint: Baseline and after 8 weeks of intervention. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Macronutrients intake. Timepoint: before and after 8 weeks intervention. Method of measurement: 24-h recall Questionnaire.;Anthropometric index(weight and Body Mass Index). Timepoint: before and after 8 weeks intervention. Method of measurement: Analogue scale for weight and weight(Kg)/Square Height for body mass index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tabriz University of Medical Sciences